These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 16986066)

  • 1. The complete remission concept.
    Mönnikes H
    Drugs Today (Barc); 2006 Jul; 42 Suppl B():9-14. PubMed ID: 16986066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Look--but also listen! ReQuest: an essay on a new validated scale to assess the outcome of GERD treatment.
    Bardhan KD; Berghöfer P
    Digestion; 2007; 75 Suppl 1():87-100. PubMed ID: 17489037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ReQuest-- the challenge of quantifying both esophageal and extra-esophageal manifestations of GERD.
    Stanghellini V
    Best Pract Res Clin Gastroenterol; 2004; 18 Suppl():27-30. PubMed ID: 15588792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Look--but also listen! ReQuest: A new dimension-oriented GERD symptom scale.
    Bardhan KD
    Drugs Today (Barc); 2004 Mar; 40 Suppl A():15-9. PubMed ID: 15190383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ReQuest: new dimensions in the assessment and management of GERD.
    Stanghellini V
    Drugs Today (Barc); 2005 Jul; 41 Suppl B():7-11. PubMed ID: 16200226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the GSFQ, a self-administered symptom frequency questionnaire for patients with gastroesophageal reflux disease.
    Paré P; Meyer F; Armstrong D; Pyzyk M; Pericak D; Goeree R
    Can J Gastroenterol; 2003 May; 17(5):307-12. PubMed ID: 12772004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The concept of complete remission of gastro-oesophageal reflux disease : comparative efficacy of pantoprazole and esomeprazole using the ReQuest questionnaire.
    Thomson AB
    Clin Drug Investig; 2007; 27(10):663-72. PubMed ID: 17803341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel measurement of rapid treatment success with ReQuest: first and sustained symptom relief as outcome parameters in patients with endoscopy-negative GERD receiving 20 mg pantoprazole or 20 mg esomeprazole.
    Mönnikes H; Pfaffenberger B; Gatz G; Hein J; Bardhan KD
    Digestion; 2007; 75 Suppl 1():62-8. PubMed ID: 17489034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower esophageal sphincter injections for the treatment of gastroesophageal reflux disease.
    Watson TJ; Peters JH
    Thorac Surg Clin; 2005 Aug; 15(3):405-15. PubMed ID: 16104131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel measurement of rapid treatment success with ReQuest: first and sustained symptom relief as outcome parameters in patients with endoscopy-negative GERD receiving 20 mg pantoprazole or 20 mg esomeprazole.
    Mönnikes H; Pfaffenberger B; Gatz G; Hein J; Bardhan KD
    Digestion; 2005; 71(3):152-8. PubMed ID: 15870503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of pantoprazole versus ranitidine in the treatment of patients with symptomatic gastroesophageal reflux disease.
    van Zyl J; van Rensburg C; Vieweg W; Fischer R
    Digestion; 2004; 70(1):61-9. PubMed ID: 15297779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pantoprazole 40 mg is as effective as esomeprazole 40 mg to relieve symptoms of gastroesophageal reflux disease after 4 weeks of treatment and superior regarding the prevention of symptomatic relapse.
    Glatzel D; Abdel-Qader M; Gatz G; Pfaffenberger B
    Digestion; 2006; 74(3-4):145-54. PubMed ID: 17230024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastroesophageal reflux disease in intellectually disabled individuals: leads for diagnosis and the effect of omeprazole therapy.
    Bohmer CJ; Niezen-de Boer MC; Klinkenberg-Knol EC; Tuynman HA; Voskuil JH; Devillé WL; Meuwissen SG
    Am J Gastroenterol; 1997 Sep; 92(9):1475-9. PubMed ID: 9317066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding GERD symptoms in the clinical setting.
    Holtmann G
    Drugs Today (Barc); 2005 Jul; 41 Suppl B():13-7. PubMed ID: 16200227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease.
    Carlsson R; Dent J; Bolling-Sternevald E; Johnsson F; Junghard O; Lauritsen K; Riley S; Lundell L
    Scand J Gastroenterol; 1998 Oct; 33(10):1023-9. PubMed ID: 9829354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of ReQuest-based symptom thresholds to define symptom relief in GERD clinical studies.
    Stanghellini V; Armstrong D; Mönnikes H; Berghöfer P; Gatz G; Bardhan KD
    Digestion; 2005; 71(3):145-51. PubMed ID: 15870502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter, randomized, double-blind study comparing 10, 20 and 40 mg pantoprazole in children (5-11 years) with symptomatic gastroesophageal reflux disease.
    Tolia V; Bishop PR; Tsou VM; Gremse D; Soffer EF; Comer GM;
    J Pediatr Gastroenterol Nutr; 2006 Apr; 42(4):384-91. PubMed ID: 16641576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ReQuest: a new questionnaire for the simultaneous evaluation of symptoms and well-being in patients with gastro-oesophageal reflux.
    Ducrotté P; Zerbib F
    Digestion; 2007; 75 Suppl 1():79-86. PubMed ID: 17489036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of GERD symptoms during therapy. Part I. Development of the new GERD questionnaire ReQuest.
    Bardhan KD; Stanghellini V; Armstrong D; Berghöfer P; Gatz G; Mönnikes H
    Digestion; 2007; 75 Suppl 1():32-40. PubMed ID: 17489030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pantoprazole 40 mg is as effective as esomeprazole 40 mg to relieve symptoms of gastroesophageal reflux disease after 4 weeks of treatment and superior regarding the prevention of symptomatic relapse.
    Glatzel D; Abdel-Qader M; Gatz G; Pfaffenberger B
    Digestion; 2007; 75 Suppl 1():69-78. PubMed ID: 17489035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.